Azitra, Inc.

AMEX:AZTR

Biotechnology

Healthcare
$1.53 +113.99%

+$0.82 today

Market cap
$92.72M
Beta
-1.04
P/E (TTM)
-1.2
EPS (TTM)
-$0.64
52W Low $0.05High $2.13

Volume 146.25M

Average 11.12M

Returns on capital

Azitra, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-288.2%

avg -153.8%

ROIC

-259.7%

avg -182.6%

ROA

-218.0%

avg -159.4%

Analysis

ROA is currently the strongest return metric at -218.0% versus its period average of -159.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Francisco D. Salva

President, Chief Executive Officer & DirectorUSD 566.58K550<0.01%

Norman Staskey

Chief Financial Officer & TreasurerUSD 493.64K56——

Travis Whitfill

Co-Founder, Chief Operating Officer, Secretary & DirectorUSD 485.36K3664.30K0.11%

Compensation is shown in the reported currency; data updated Oct 26, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jun 16, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

3

$999,817.80

Sells

0

$0.00

Net Transaction Value

+$999,817.80

Net buying

Most Active

Salva Francisco D.

3 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Mar 18, 26

Salva Francisco D.

Direct

Buy$499.9K
Mar 18, 26

Salva Francisco D.

Direct

Buy$499.9K
Mar 18, 26

Salva Francisco D.

Direct

Buy$61.5

Summary

Insiders reported 3 buys worth $999,817.80 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $999,817.80. Salva Francisco D. was the most active insider with 3 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Azitra, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Competitors

Peer companies in the same sector

Health

Questions

Management questions

Common questions about AZTR's management, answered from reported figures.

Who manages AZTR?

Azitra, Inc. (AZTR) lists 3 active executives. The top listed executive is Francisco D. Salva, President, Chief Executive Officer & Director.

Are AZTR insiders buying or selling?

Recent insider activity shows net buying of $6.32B.